Education
About Us
Working with TipRanks
Follow Us
Appili Therapeutics Inc Class A (TSE:APLI)
:APLI
APLI Stock Chart & Stats
C$0.03
>-C$0.01(-14.29%)
At close: 4:00 PM EST
C$0.03
>-C$0.01(-14.29%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.05
Previous CloseN/A
Volume36.33K
Average Volume (3M)437.08K
Market Cap
C$3.64M
Enterprise ValueC$13.05M
Total Cash (Recent Filing)C$1.13M
Total Debt (Recent Filing)C$12.35M
Price to Earnings (P/E)―
Beta1.41
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding121,266,120
10 Day Avg. Volume72,400
30 Day Avg. Volume437,084
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Appili Therapeutics Inc Class A News
APLI FAQ
What was Appili Therapeutics Inc Class A’s price range in the past 12 months?
Appili Therapeutics Inc Class A lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Appili Therapeutics Inc Class A’s market cap?
Appili Therapeutics Inc Class A’s market cap is C$3.64M.
When is Appili Therapeutics Inc Class A’s upcoming earnings report date?
Appili Therapeutics Inc Class A’s upcoming earnings report date is Nov 13, 2025 which is in 21 days.
How were Appili Therapeutics Inc Class A’s earnings last quarter?
Appili Therapeutics Inc Class A released its earnings results on Aug 14, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Appili Therapeutics Inc Class A overvalued?
According to Wall Street analysts Appili Therapeutics Inc Class A’s price is currently Overvalued.
Does Appili Therapeutics Inc Class A pay dividends?
Appili Therapeutics Inc Class A does not currently pay dividends.
What is Appili Therapeutics Inc Class A’s EPS estimate?
Appili Therapeutics Inc Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Appili Therapeutics Inc Class A have?
Appili Therapeutics Inc Class A has 121,266,120 shares outstanding.
What happened to Appili Therapeutics Inc Class A’s price movement after its last earnings report?
Appili Therapeutics Inc Class A reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Appili Therapeutics Inc Class A?
Currently, no hedge funds are holding shares in TSE:APLI
Company Description
Appili Therapeutics Inc Class A
Appili Therapeutics Inc. is a biotechnology company focused on developing novel antimicrobial and antiviral therapies. The company operates primarily in the pharmaceutical sector, concentrating on addressing unmet medical needs related to infectious diseases. Appili's core products include its leading candidate, ATI-1501, which is an oral formulation of the antibiotic metronidazole, aimed at treating infections caused by Clostridium difficile. The company is also engaged in other projects focusing on the development of therapies for resistant bacterial infections and viral diseases.
Technical Analysis
Restart Life Sciences
―
Rakovina Therapeutics Inc
―
MYND Life Sciences
―
Marvel Biosciences Corp
―
―